论文部分内容阅读
目的 探讨重组人红细胞生成素 (r HuEPO)治疗慢性肾衰血透病人贫血的临床疗效。方法 给 60例慢性肾衰贫血病人于透析后皮下注射r HuEPO ,并动态观察红细胞计数 (RBC)、红细胞压积 (HCT)、血红蛋白 (Hb)、网织红细胞 (Rc)的变化。结果 病人的贫血症状明显改善 ,RBC、Hb、HCT、Rc与治疗前相比明显增高 (P <0 0 5)。结论 r HuEPO对慢性肾衰血透病人的贫血有可靠疗效
Objective To investigate the clinical efficacy of recombinant human erythropoietin (r HuEPO) in the treatment of anemia in patients with chronic renal failure and hemodialysis. Methods Sixty chronic anemia patients with chronic renal failure were injected subcutaneously with r HuEPO after dialysis, and the changes of RBC, HCT, Hb and Rc were observed. Results The patient’s symptoms of anemia were significantly improved. RBC, Hb, HCT and Rc were significantly higher than those before treatment (P <0.05). Conclusion r HuEPO has a reliable effect on anemia in patients with chronic renal failure